PE Conjugated CD45RO Recombinant Mouse Monoclonal Antibody [PSH13-94]
Antibody Type
Recombinant Mouse Monoclonal Antibody
Species Reactivity
Human
Validated Applications
FC
Target Molecular Weight
Predicted band size: 131 kDa
Positive Control
Human peripheral blood cells.
Conjugation
PE
Clone Number
PSH13-94
Reactivity Data
Tested Verified (internally validated)
Published Reported in literature (not internally validated)
Predicted Predicted reactive (based on sequence homology)
Not recommended Not recommended (failed internal validation)
FC
Human
Product Features
Form
Liquid
Concentration
/(The concentration of this product may be batch-dependent)
Lot Concentration Lookup
Storage Instructions
Store at 2-8℃. Avoid freeze.
Storage Buffer
1*PBS (pH7.4), 1% BSA, 0.2% Proclean 950.
Isotype
IgG1
Purification Method
Protein A affinity purified.
Application Dilution
FC
5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood.
Target
Function
Protein tyrosine phosphatase, receptor type, C also known as PTPRC is an enzyme that, in humans, is encoded by the PTPRC gene. PTPRC is also known as CD45 antigen (CD stands for cluster of differentiation), which was originally called leukocyte common antigen (LCA). PTPRC is a critical enzyme involved in regulating immune cell function. PTPRC is a transmembrane protein tyrosine phosphatase expressed on the surface of all nucleated hematopoietic cells, particularly lymphocytes. It plays a key role in the activation and differentiation of T cells, B cells, and other immune cells by modulating signaling pathways. It functions by dephosphorylating specific tyrosine residues on target proteins, thereby controlling various signaling processes essential for immune response and homeostasis. Naive T lymphocytes are typically positive for CD45RA, which includes only the A protein region. Activated and memory T lymphocytes express CD45RO, the shortest CD45 isoform, which lacks all three of the A, B, and C regions. This shortest isoform facilitates T cell activation.
Background References
1. Mohammadi Y et al. CD45RO+TILs: cellular biomarkers for larynx squamous cell carcinoma outcome. Braz J Otorhinolaryngol. 2022 Nov-Dec
2. Kandel A et al. Differential Expression of CD45RO and CD45RA in Bovine T Cells. Cells. 2022 Jun
Flow cytometric analysis of human peripheral blood cells labeling CD45RO (HA601531F, PE).
Cells were washed twice with cold PBS and resuspend. Then incubated for 1 hour at +4℃ with CD45RO (HA601531F, PE, 1/1,000) (red). Unlabelled sample was used as a control (cells without incubation with primary antibody; black).
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"